Background: Atopic dermatitis (AD) and other atopic diseases often share some common genetic and pathogenic bases. Recent genome-wide association studies (GWAS) have identified several loci associated with atopic diseases, allergic sensitization and asthma in different populations. The aim of this study was to investigate whether these susceptibility loci were related to AD in Chinese Han population.
Introduction
Atopic dermatitis (AD) is a common chronic relapsing, pruritic and inflammatory skin disease caused by the combined interaction between genetic and environmental factors.
1 AD has become a global health problem with prevalence ranging from 3.0% to 17.0% in the general population worldwide 2 and from 8.3% 3 to 11.8% 4 in China. AD, allergic rhinitis (AR) and asthma belong to atopic diseases and often coexist. Globally, the co-morbidity rate of these three diseases were 5.1-13.6% in asthma patients, 4.3-21.2% in rhinoconjunctivitis patients and 8. [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] .1% in eczema patients. 2 A number of genetic factors had been observed in patients with atopic diseases, which suggested that common predisposing genetic factors might be involved in these diseases. 5 Our previous genome-wide association studies (GWAS) of AD have identified 2 loci relate to AD. 6 Allergic sensitization is a multifactorial process that is influenced by the allergen and its biological function per se as well as other small molecular compounds. 7 It is an important risk factor for the development of atopic disease 8 and has an estimated heritability of 0.40-0.85. 9 Many susceptibility loci of allergic sensitization have been reported. Hinds et al. 10 performed a genome-wideassociation studies (GWAS) meta-analysis of allergic sensitization susceptibility loci in European population with self-reported cat, dust-mite and pollen allergies. They
Methods

Study Subjects
A total of 3,013 AD patients including of 1824 (60.54%) males and 1189 (39.46%) females with the mean age of 5.51 ±7.93 years and 5,483 controls including of 2742 (50.01%) males and 2741 (49.99%) females with the mean age of 28.41 ±13.70 years were enrolled in this study. All DNA samples were from Chinese Han population. The patients fulfilled the Hannifin-Rajka criteria 11 and the controls were healthy individuals without AD, other atopic diseases, systemic disorders or family history of AD (including first-, secondand third-degree relatives). Informed consent was obtained from all individual participants included in the study. The study was approved by the Institutional Ethical Committee of Anhui Medical University and was conducted according to the Declaration of Helsinki principles.
SNP selection
After excluding the SNPs evaluated in the previously replications in Chinese population, eight SNPs were selected for 5q31 and 5q22.1 related to atopic dermatitis 197 analysis in this study (Table 1) , including five SNPs (rs2101521 at 4p14, rs1438673 at 5q22.1, rs7720838 at 5p13.1, rs6021270 at 20q13.2, rs3771175 at 2q12.1) associated with allergic sensitizationin in Americans and Europeans, 9, 10 two SNPs (rs1469621 at 2q22 and rs2158177 at 5q31)related to AD with athsma in an AD-GWAS of Europeans, 12 and one SNP (rs1837253 at 5q22.1) associated with athsma in adult and allergic rhinitis with asthma in children. 13, 14 Genotyping and quality controls Genomic DNA was extracted using QIAamp DNA Blood KIT (Qiagen, Valencia, CA, USA). SNPs were genotyped using the Sequenom MassArray system. The DNA of each sample was amplified by multiplex polymerase chain reaction (PCR) reactions, and PCR products were used for locus -specific single-base extension reactions. Then, the reactions products were desalted and transferred to a 384-element Spectro-CHIP array, alleles detection was performed using MALDI-TOF MS. The mass spectrograms were analyzed by MassARRAYTyper software (Sequenom). Exclusion criteria for the genotyped SNPs were call rate < 95%, minor allele frequency (MAF) < 0.05, and deviation from Hardy -Weinberg equilibrium (HWE, P < 0.05) in the controls.
Statistical Analysis
The possible associations of the eight SNPs with AD and its subphenotypes were assessed by using Plink 1.07 software. 15 The strength of association was estimated by calculating the odds ratio (OR) with a 95% confidence interval (95%CI). The association model (dominant, recessive, additive) of each allele was tested using the Pearson's chi-square test. Conservatively accounting for the multiple comparisons by the Bonferroni correction, the threshold for statistical significance was P < 6.3×10 -3 (0.05/8). The genetic statistical power for all genotyped SNPs was estimated using the CaTS-Power Calculator. ), including 8 loci previously associated with asthma, as well as 8 novel loci. A similar study identified ten single nucleotide polymorphisms (SNPs) with allergic sensitization in European descent population. 9 In present study, we selected eight SNPs from recent AD, asthma and allergic sensitization GWAS in different populations to investigate whether these genetic variants are associated with AD in Chinese Han population. Consequently, we found that genetic variants in 5q31 and 5q22.1 were significantly associated with AD in Chinese Han population. Moreover, bioinformatics analysis conformed that both loci were associated with the JAK-STAT signaling pathway which plays an important role in the pathogenesis of AD.
Results
Association between AD and SNPs
All the SNPs passed the quality control. The association analysis for the eight SNPs between cases and controls was shown in Table 2 . The SNP rs2158177 (P = 1.08×10 -3 , OR = 1.15, 95%CI = 1.06-1.24) at 5q31 and rs1837253 (P = 2.66× 10 -3 , OR = 0.91, 95%CI = 0.85-0.97) at 5q22.1 were significantly associated with AD after correcting for multiple testing (P Bonferroni < 6.3×10 -3 ). There was no significant association between AD cases and controls for any other SNPs. Genotype -based association analysis revealed that the dominant model ) and rs1837253 (P = 5.30×10 -3 ) ( Table 3) .
Bioinformatics analysis of validated SNPs for putative pathways
The two SNPs which were validated in the Chinese Han population were analyzed for their positions relative to nearby genes using the LocusZoom. 16 Interestingly, the rs2158177 falls in the RAD50/IL13 region (Figure 1 ) and the rs1837253 is located 5.7 kb upstream of the transcription initiation region of TSLP (Figure 2) . The KOBAS 2.0 computer program (http://kobas.cbi.pku.edu.cn/home.do.) was applied to identify biological pathways that these genes may be involved and their relations to AD. We found that IL13 was associated with nine signaling pathways. In addition, both IL13 and TSLP were strongly associated with JAK-STAT signaling pathway, but no pathway was related to RAD50. Information about the potential pathways to these genes has been summarized in Table 4 .
Discussion
AD is a complex genetic disease, which often develops with asthma, allergic rhinitis and other allergic diseases. 17 Although the atopic march was generally accepted, it is still debated whether it is due to their sharing common genetic factors. 18 Therefore, understanding the genetic relationships between AD and other allergic states might help to further elucidating the pathogenesis of AD. Here we investigated eight SNPs located in different genes, which were susceptibility loci for atopic diseases, allergic sensitization and asthma in European, American and Japanese populations and analyzed their association with AD in Chinese Han population. Interestingly, 2 SNPs in 5q31 and 5q22.1 showed significant differences between AD patients and controls.
Chromosome 5q31-32 is considered a critical region for several allergic and atopic diseases, including asthma. rs17690965 at 5q31.1 is a susceptibility loci for atopic march. 19 Functional polymorphism C-159Tof the CD14 promoter region might play a role in the pathogenesis of nasal polyposis and in the incidence of asthma. 20 rs2158177 in the 5q31 falls in the RAD50/IL13 region. The protein encoded by RAD50 forms a complex with MRE11 and NBS1, and is important for DNA double-strand break repair, cell cycle checkpoint activation, telomere maintenance, and meiotic recombination. 21 However, it has no known function directly related to AD. On the contrary, IL13 encodes an immunoregulatory cytokine produced primarily by activated Th2 cells. IL13 is critical to the pathogenesis of both atopy and asthma. 22, 23 The SNP rs1837253 at 5q22.1, which was not in the same LD with rs7701890 (P combined = 3.15 × 10 −9 , OR= 1.24) reported by our previous GWAS 6 (r 2 < 0.01) through Haploview 4.2, is located 5.7 kb upstream of the transcription initiation region of TSLP. It is a susceptibility gene for allergic diseases and plays an important role in these diseases. 24 Tang et al 25 in our study group also detected one significant risk haplotype GGGA from 4 SNPs (rs10067777, rs7701890, rs13360927 and rs13361382) at 5q22.1 in AD cases and the haplotype was suggestive of risk in asthma cases, which suggested that 5q22.1 might be shared by AD and asthma in Chinese Han population.
A recent study indicated that IL13 induces AD and atopic march via a TSLP dependent mechanism. 26 Interestingly, through pathway annotation analysis using KOBAS 2.0, we found that both IL13 and TSLP are strongly associated with JAK-STAT signaling pathway. The JAK-STAT pathway is a classical signal transduction pathway for numerous cytokines and growth factors. The TSLP is high expressed in acute and chronic lesions of AD patients 27 and plays an important role in stimulating neurons and provoking itch in AD patients. 28 The human TSLP receptor activates STAT1, STAT3, STAT5/ JAK1, JAK2 and promotes the differentiation of Th2 cells. 29, 30 Then, Th2 cells produce IL4, IL-5, and IL13, which activate eosinophils, affect B cell maturation and plays an essential role in the dysregulation of immune responses in AD (Figure 3) . 31 In contrast to the therapeutic applications existing for haematology and rheumatology, there are no licensed dermatological indications for JAK or STAT inhibitors. 32 Through our analysis, JAK-STAT signaling pathway may be a potential therapeutic target for the treatment of AD. IL13 can suppress human cathelicidin LL-37 through STAT6 in eczema vaccinatum of AD patients. 33 Loricrin and involucrin are two 5q31 and 5q22.1 related to atopic dermatitis 201 important factors for skin barrier function and downregulated by IL4 and IL13 in keratinocytes. 34 Here we found that two SNPs in 5q31 and 5q22.1 showed significantly differences between AD patients and controls while the other six SNPs were not related to AD. That might be caused by racial differences. Furthermore, in these six SNPs we noticed that the statistical power of three SNPs in 20q13.2, 2q12.1 and 2q22 were less than 80%, which might be the reason why these three SNPs were not associated with AD in our study and called for more subjects in further study to confirm these findings from independent cohorts. In summary, this study indicates that 5q31(RAD50/ IL13) and 5q22.1(TSLP) are associated with AD and confer susceptibility to AD. Pathway analysis reveals that both IL13 and TSLP are associated with JAK-STAT signaling pathway which plays an influential role in the pathogenesis of AD. To further analyze the true susceptibility gene for AD within these loci, fine mapping and functional studies is needed.
